1,1-Difluoroethane Hydrocarbon Cardiomyopathy.
JACC Case Rep 2022;
7:101716. [PMID:
36776796 PMCID:
PMC9911916 DOI:
10.1016/j.jaccas.2022.101716]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2022] [Revised: 10/26/2022] [Accepted: 11/23/2022] [Indexed: 12/24/2022]
Abstract
1,1-Difluoroethane (DFE) cardiomyopathy results from the direct inhalation of toxic halogenated hydrocarbons. We present a case series of acute DFE cardiomyopathy illustrating the typical presentation of severe DFE cardiomyopathy along with a detailed description of its mechanism of injury. (Level of Difficulty: Advanced.).
Collapse